COVID-19 associated changes in the right departments of the heart in the elderly people
Abstract. Purpose of the work: to study the indicators characterizing heart lesions in elderly patients who had carried COVID-19.
Materials and methods: 86 patients older than 60 years old, were examined, of whom 56 (32 women and 24 men) who have carried COVID-19 between 3 and 6 months before the study, and 30 patients (12 men and 18 women) who did not have COVID - 19 in the anamnesis. The patients have been examined clinically, electro and echocardiography have been performed.
The results. Elderly patients during the post-covid period have complaints of shortness of breath, pain in the heart, swelling, coughing, weakness, which are more stable and intense than before the infection. Patients who have carried COVID-19 demonstrate the signs of a chronic pulmonary heart disease: increase in the size of a right ventricle and decrease of its contractile ability, increase in pressure in a pulmonary artery. Signs of a statistically significant moderate decrease of the contractility in the left ventricular were also identified.
Conclusions. The statistically significant changes in the right departments of the heart among the patients with carried COVID-19 with persistent symptoms after infection were defined. Patients who have carried COVID-19 but have no symptoms did not differ statistically from the control group.
Iba, T.; Connors, J. M.; Levy, J. H. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 2020, 12, 1–9. https://dx.doi.org/10.1007%2Fs00011-020-01401-6
Long, B.; Brady, W. J.; Koyfman, A.; Gottlieb, M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020, 38, 7, 1504-1507. https://dx.doi.org/10.1016%2Fj.ajem.2020.04.048
Rosa, G. M.; D'Agostino, A.; Giovinazzo, S.; La Malfa, G.; Fontanive, P. et al. Echocardiography of right ventricular-arterial coupling predicts survival of elderly patients with heart failure and reduced to mid-range ejection fraction. Monaldi Archives for Chest Disease, 2020, 90, 2. https://doi.org/10.4081/monaldi.2020.1269
Rhodes, R. H.; Love, G. L.; Lameira, F. D. S.; Sadough, M. S.; Fox, S. E. & Vander Heide, R. S. Acute endotheliitis (type 3 hypersensitivity vasculitis) in ten COVID-19 autopsy brains. medRxiv 2021, 1-13. https://doi.org/10.1101/2021.01.16.21249632
Varga, Z.; Flammer, A. J.; Steiger, P.; Haberecker, M.; Andermatt, R. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020,, 395, 10234, 1417–1418. https://doi.org/10.1016
Zhang, J.; Tecson, K. M. & McCullough, P. A. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Reviews in cardiovascular medicine 2020, 21, 3, 315–319. https://doi.org/10.31083/j.rcm.2020.03.126
Bernard, I.; Limonta, D.; Mahal, L. K. & Hobman, T. C. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2020, 13, 1, 29. https://doi.org/10.3390/v13010029
Avdeev, S. N. Modern approaches to the diagnosis and treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Pulmonology 2009, 1, 90-101. (in Russian) https://doi.org/10.18093/0869-0189-2009-0-1-90-101
Lefer, A. N.; Lefer, D. J. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Ann. Rev. Pharmacol. Toxicol. 1993, 33, 71–90. https://doi.org/10.1146/annurev.pa.33.040193.000443
Maccio, U.; Zinkernagel, A. S.; Shambat, S. M.; Zeng, X.; Cathomas, G. et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine 2021, 63, 103182. https://doi.org/10.1016/j.ebiom.2020.103182
Gopinathannair, R.; Merchant, F.; Lakkireddy, D.; Etheridge, S. P.; Fiegovsky, S. et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol 2020, 10, 4, 1‐8. https://doi.org/10.1007/s10840-020-00789-9
Klein, C. L.; Kohler, H.; Bittinger, F.; Wagner, M.; Hermanns, I. et al.Comparative studies on vascular endothelium in vitro. Pathobiol 1994, 62, 199–208. https://doi.org/10.1159/000163928
Gavrisyuk, V. K. Chronic cor pulmonale: mechanisms of pathogenesis and principles of therapy. Ukrainian pulmonological journal 2006, 4, 6-13. (in Russian)
Elias, P.; Poterucha, T. J.; Jain, S. S.; Sayer, G.; Raikhelkar, J. et al.The prognostic value of electrocardiogram at presentation to emergency department in patients with COVID-19. Mayo Clin Proc 2020, 95, 10, 2099–2109. https://dx.doi.org/10.1016%2Fj.mayocp.2020.07.028
Zhang, J., Tecson, K. M., & McCullough, P. A. Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19). Proceedings 2021, 34, 2, 262–268. https://doi.org/10.1080/08998280.2021.1874231
Blagova, O. V., Kogan, E. A., Lutokhina, Y. A., Kukleva, A. D., Ainetdinova, D. H. et al. Subacute and chronic post-covid myoendocarditis: clinical presentation, role of coronavirus persistence and autoimmune mechanisms. Kardiologiia 2021, 61, 6, 11–27. (in Russian) https://doi.org/10.18087/cardio.2021.6.n1659
Dzyga, S. V.; Bakalets, O. V.; Begosh, N. B. COVID-19-related heart disease and features of electrocardiographic changes. Scientific and practical manual, Babinets, L. S. Ed. Osadtsa Yu. V.: Ternopil, 2021, 518-530. (in Ukrainian)
Napalkov, D. A. Mineralocorticoid receptor antagonists: a dubious past and a promising present. Consilium medicum 2015, 5, 63-67. (in Russian)